Global Excipients for Orally Disintegrating Tablets (ODT) Market Growth 2024-2030
Excipients for orally disintegrating tablets (ODTs) are inactive ingredients added to the formulation to impart desirable properties such as rapid disintegration, taste-masking, and mouthfeel enhancement. Key excipients commonly used in ODTs include superdisintegrants like crospovidone, sodium starch glycolate, and croscarmellose sodium, which promote tablet breakup upon contact with saliva. Binders such as microcrystalline cellulose and polyvinylpyrrolidone are employed to impart sufficient mechanical strength to the tablet while allowing for rapid disintegration. Sweeteners, flavors, and masking agents are added to improve palatability and mask the unpleasant taste of active pharmaceutical ingredients. Lubricants and glidants aid in tablet processing and ensure smooth tablet disintegration in the mouth. Overall, excipients play a crucial role in the formulation of ODTs, enabling convenient and patient-friendly oral dosage forms with rapid dissolution and administration.
The global Excipients for Orally Disintegrating Tablets (ODT) market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Excipients for Orally Disintegrating Tablets (ODT) Industry Forecast” looks at past sales and reviews total world Excipients for Orally Disintegrating Tablets (ODT) sales in 2023, providing a comprehensive analysis by region and market sector of projected Excipients for Orally Disintegrating Tablets (ODT) sales for 2024 through 2030. With Excipients for Orally Disintegrating Tablets (ODT) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Excipients for Orally Disintegrating Tablets (ODT) industry.
This Insight Report provides a comprehensive analysis of the global Excipients for Orally Disintegrating Tablets (ODT) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Excipients for Orally Disintegrating Tablets (ODT) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Excipients for Orally Disintegrating Tablets (ODT) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Excipients for Orally Disintegrating Tablets (ODT) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Excipients for Orally Disintegrating Tablets (ODT).
United States market for Excipients for Orally Disintegrating Tablets (ODT) is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Excipients for Orally Disintegrating Tablets (ODT) is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Excipients for Orally Disintegrating Tablets (ODT) is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Excipients for Orally Disintegrating Tablets (ODT) players cover Catalent, SPI Pharma, Takeda Pharmaceutical, Fuisz Technologies, Roquette, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Excipients for Orally Disintegrating Tablets (ODT) market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Below Ten Seconds
Ten Seconds and Above
Segmentation by Application:
Pharmaceutical
Nutraceuticals
Chewable Vitamin
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Catalent
SPI Pharma
Takeda Pharmaceutical
Fuisz Technologies
Roquette
JRS Pharma
Fuji Chemical
Merck
Galvita
DAICEL
BASF
Adare Pharma
Astellas Pharma
Akina
Vitaquest
Key Questions Addressed in this Report
What is the 10-year outlook for the global Excipients for Orally Disintegrating Tablets (ODT) market?
What factors are driving Excipients for Orally Disintegrating Tablets (ODT) market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Excipients for Orally Disintegrating Tablets (ODT) market opportunities vary by end market size?
How does Excipients for Orally Disintegrating Tablets (ODT) break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.